Clin Exp Otorhinolaryngol.  2015 Mar;8(1):1-6. 10.3342/ceo.2015.8.1.1.

Do All Antioxidant Supplements Have the Same Potential Effect on Preventing Myringosclerosis?

• Akdagli S
• Tuzuner A
• Demirci S
• Karadas H
• Tulaci KG
• Dogan M
• Caylan R

• KMID: 1973480
• DOI: http://doi.org/10.3342/ceo.2015.8.1.1

Abstract

OBJECTIVES
Myringosclerosis is an irreversible pathological healing mechanism of the tympanic membrane which can result in the formation of sclerotic plaques. Antioxidant treatment is a recognised prevention therapy and coenzyme Q10 (CoQ10), lycopene, and grape seed extract (GSE), were used in this manner.
METHODS
Forty-four Wistar rats were used in this experiment, and, following myringotomies, the animals were randomly divided into four groups. CoQ10, lycopene or GSE was administered orally to the respective groups, starting from the day of surgery. Otomicroscopy examination was performed on the 14th day. All tympanic membrane lesions were evaluated and compared otomicroscopically and histopathologically.
RESULTS
The otomicroscopy and histopathological findings, compared against a control (saline) group, showed the CoQ10, lycopene, and GSE groups had statistically significant differences of degree of sclerosis (P<0.001).
CONCLUSION
CoQ10, lycopene, and GSE were compared against a saline group and their antioxidative and anti-inflammatory effects were similar. The formation of myringosclerotic plagues after experimental myringotomy in rats significantly decreased and diminished after systemic administration of the three different antioxidant supplements.

Keyword

Myringosclerosis; Grape Seed Extract; Lycopene; Coenzyme Q10; Antioxidant

MeSH Terms

Animals
Grape Seed Extract
Myringosclerosis*
Rats
Rats, Wistar
Sclerosis
Tympanic Membrane
Grape Seed Extract

Figure

• 

  Fig. 1 Coenzyme Q10 group. There is no thickening of tympanic membrane and no fibrosis (arrow) (H&E, ×200).

• 

  Fig. 2 Grape seed extract group. Grade 1 sclerosis, mild fibrotic change is highlighted with green color (arrow) (Masson's trichrome, ×200).

• 

  Fig. 3 Lycopene group. Grade 2 sclerosis, moderate thickening of tympanic membrane and fibroblastic hyperplasia (arrows) (H&E, ×200).

• 

  Fig. 4 Saline group. Grade 3 sclerosis, extensive thickening of tympanic membrane due to sclerotic changes in lamina propria (arrow) (H&E, ×100).

• 

  Fig. 5 Trichrome stain of the same rat in Fig. 4 (saline group, grade 3 sclerosis) shows marked fibrosis in lamina propria (arrow) (Masson's trichrome, ×100).

• 

  Fig. 6 Box-plot for sclerosis of tympanic membrane evaluation in histopathologic examination. Group 1, control group; Group 2, grape seed extract administered group; Group 3, coenzyme Q10 administered group; Group 4, lycopene administered group.

Reference

1. Mattsson C, Magnuson K, Hellstrom S. Myringosclerosis caused by increased oxygen concentration in traumatized tympanic membranes. Experimental study. Ann Otol Rhinol Laryngol. 1995; 8. 104(8):625–632. PMID: 7639472.

2. Ho KY, Tsai SM, Chai CY, Wang HM. Clinical analysis of intratympanic tympanosclerosis: etiology, ossicular chain findings, and hearing results of surgery. Acta Otolaryngol. 2010; 3. 130(3):370–374. PMID: 19685361.

3. Kazikdas KC, Uguz MZ, Erbil G, Tugyan K, Yilmaz O, Guneli E, et al. The anti-oxidant effect of alpha-tocopherol in the prevention of experimentally induced myringosclerosis. Otol Neurotol. 2006; 9. 27(6):882–886. PMID: 16788415.

4. Ozcan C, Gorur K, Cinel L, Talas DU, Unal M, Cinel I. The inhibitory effect of topical N-acetylcysteine application on myringosclerosis in perforated rat tympanic membrane. Int J Pediatr Otorhinolaryngol. 2002; 5. 63(3):179–184. PMID: 11997152.

5. Polat S, Ozturk O, Uneri C, Yuksel M, Haklar G, Bozkurt S, et al. Determination of reactive oxygen species in myringotomized tympanic membranes: effect of vitamin e treatment. Laryngoscope. 2004; 4. 114(4):720–725. PMID: 15064630.

6. Spratley JE, Hellstrom SO, Mattsson CK, Pais-Clemente M. Topical ascorbic acid reduces myringosclerosis in perforated tympanic membranes. A study in the rat. Ann Otol Rhinol Laryngol. 2001; 6. 110(6):585–591. PMID: 11407852.

7. Emir H, Kaptan ZK, Samim E, Sungu N, Ceylan K, Ustun H. The preventive effect of ginkgo biloba extract in myringosclerosis: study in rats. Otolaryngol Head Neck Surg. 2009; 2. 140(2):171–176. PMID: 19201283.

8. Uneri C, Baglam T, Yazici M. The effect of vitamin E treatment on the development of myringosclerosis after ventilation tube insertion. Int J Pediatr Otorhinolaryngol. 2006; 6. 70(6):1045–1048. PMID: 16368152.

9. Bentinger M, Brismar K, Dallner G. The antioxidant role of coenzyme Q. Mitochondrion. 2007; 6. 7(Suppl):S41–S50. PMID: 17482888.

10. Beyer RE. An analysis of the role of coenzyme Q in free radical generation and as an antioxidant. Biochem Cell Biol. 1992; 6. 70(6):390–403. PMID: 1333230.

11. Mordente A, Guantario B, Meucci E, Silvestrini A, Lombardi E, Martorana GE, et al. Lycopene and cardiovascular diseases: an update. Curr Med Chem. 2011; 18(8):1146–1163. PMID: 21291369.

12. Bignotto L, Rocha J, Sepodes B, Eduardo-Figueira M, Pinto R, Chaud M, et al. Anti-inflammatory effect of lycopene on carrageenan-induced paw oedema and hepatic ischaemia-reperfusion in the rat. Br J Nutr. 2009; 7. 102(1):126–133. PMID: 19203414.

13. Reifen R, Nissenkorn A, Matas Z, Bujanover Y. 5-ASA and lycopene decrease the oxidative stress and inflammation induced by iron in rats with colitis. J Gastroenterol. 2004; 6. 39(6):514–519. PMID: 15235867.

14. Bagchi D, Garg A, Krohn RL, Bagchi M, Tran MX, Stohs SJ. Oxygen free radical scavenging abilities of vitamins C and E, and a grape seed proanthocyanidin extract in vitro. Res Commun Mol Pathol Pharmacol. 1997; 2. 95(2):179–189. PMID: 9090754.

15. Ray S, Bagchi D, Lim PM, Bagchi M, Gross SM, Kothari SC, et al. Acute and long-term safety evaluation of a novel IH636 grape seed proanthocyanidin extract. Res Commun Mol Pathol Pharmacol. 2001; Mar-Apr. 109(3-4):165–197. PMID: 11758648.

16. Bhaya MH, Schachern PA, Morizono T, Paparella MM. Pathogenesis of tympanosclerosis. Otolaryngol Head Neck Surg. 1993; 9. 109(3 Pt 1):413–420. PMID: 8414556.

17. Mattsson C, Marklund SL, Hellstrom S. Application of oxygen free radical scavengers to diminish the occurrence of myringosclerosis. Ann Otol Rhinol Laryngol. 1997; 6. 106(6):513–518. PMID: 9199613.

18. Song JJ, Lim HW, Kim K, Kim KM, Cho S, Chae SW. Effect of caffeic acid phenethyl ester (CAPE) on H₂O₂ induced oxidative and inflammatory responses in human middle ear epithelial cells. Int J Pediatr Otorhinolaryngol. 2012; 5. 76(5):675–679. PMID: 22370236.

19. Gorur K, Ozcan C, Polat A, Unal M, Tamer L, Cinel I. The anti-oxidant and anti-apoptotic activities of selenium in the prevention of myringosclerosis in rats. J Laryngol Otol. 2002; 6. 116(6):426–429. PMID: 12385352.

20. Jayaprakasha GK, Selvi T, Sakariah KK. Antibacterial and antioxidant activities of grape (Vitis vinifera) seed extracts. Food Res Int. 2003; 36(2):117–122.